AzTrials
AzTrials

BPHProstateNCT05330156

Transurethral Resection Versus Transurethral Enucleation of the Prostate: Prospective Randomized Study

A study testing Transurethral resection of the prostate and transurethral enucleation of prostate in people with BPH, run by Assiut University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

TUERP technique could be used in prostates of all sizes with the same safety and efficacy "size independent procedure" . TUERP could be performed using the bipolar system only ,with or without the use of morcellator. Read more about this study

Who is it for?
Any age, men only
Conditions the study is for
BPH
What is being tested?
Transurethral resection of the prostate and transurethral enucleation of prostate
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
58 participants
Where
1 siteEgypt
Study dates
30 Apr 2022to 30 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Men only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • -Patients aging from 50 to 80 years old who are diagnosed with clinical symptomatic BPH.
  • The patients have clear indi¬cation for endoscopic surgery (according to the guidelines).
  • Clinically fit patients for surgery.
  • Signed an informed consent.

Who cannot join

  • Prostate cancer Previous urethral or prostate surgery Neurogenic bladder Urethral stricture Poor general condition of the patient

Trial locations and contacts

1 site in 1 country.

Ahmed F Hassan, Master contact

01069569946

ahmedfarahat358@gmail.com

Egypt1 site
  • assiut University

    Asyut, 71715

Other trials in Egypt

About this study

TUERP technique could be used in prostates of all sizes with the same safety and efficacy "size independent procedure" . TUERP could be performed using the bipolar system only ,with or without the use of morcellator.

Read the detailed description

Transurethral resection of the prostate (TURP) was first done in the 1920s. Since then, TURP has been considered as the gold standard treatment for BPH . However, its relatively high complication rate and postoperative recurrence necessitates further modification in the surgery technique .The resected adenomas have been reported to recur in up to 15% of cases that need a repeat surgical intervention, even by experienced surgeons in high-volume centers .

Before the era of TURP, simple open prostatectomy was the mainstay of surgical therapy. However, open simple prostatectomy has high risk of considerable intraoperative bleeding requiring transfusion. The lower abdominal incision done in open prostatectomy may result in significant postoperative pain, an extended recovery period and longer hospital stay, with greater morbidity and a perioperative mortality rate of 0.2%. In addition, TURP for large prostatic adenomas causes significantly much more bleeding with clot retention as compared to simple open prostatectomy, it also need a longer operative time, which leads to increased risk of TUR syndrome with subsequent morbidity . A new technique in which transurethral enucleation and resection of the prostate (TUERP) was developed and adopted to replicate the open enucleation of prostatic adenomas in an endoscopic way. This will combine the benefits of complete prostate enucleation in a minimally invasive technique . prostate enucleation by laser currently used as minimally invasive and save alternative to TURP, but still has not been widely accepted for some reasons, including high cost and prolonged learning curve.

TUERP technique could be used in prostates of all sizes with the same safety and efficacy "size independent procedure" . TUERP could be performed using the bipolar system only ,with or without the use of morcellator

Conditions
BPH
Being tested
Transurethral resection of the prostate, transurethral enucleation of prostate

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transurethral resection of the prostateProcedure or surgery

    • After an initial cysto-urethroscopy assessment done, Transurethral resection of the prostate is performed using the bipolar system with normal saline irrigation, under spinal or general anesthesia.
  • transurethral enucleation of prostateProcedure or surgery

    After an initial cysto-urethroscopy assessment done, transurethral enucleation of prostate is performed using the bipolar system with normal saline irrigation, under spinal or general anesthesia.

Study groups in NCT05330156
Study groupRoleWhat they receive
Transurethral resection of the prostate group (TURP).Active comparatorthe 1st group of patients will undergone Transurethral resection of the prostate for treatment of BPH
Receives: Procedure: Transurethral resection of the prostate
transurethral enucleation of prostate group (TUEP)Active comparatorthe 2nd group of patients will undergone Transurethral enucleation of the prostate for treatment of BPH
Receives: Procedure: transurethral enucleation of prostate

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time of operation

    time used for resection or enucleation and resection of the prostate

    Measured: intraoperative (from the start of resection or enucleation till the fixation of urethral catheter)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2022
  2. Study start30 Apr 2022 (estimated)
  3. Primary completion30 Mar 2024 (estimated)
  4. Study completion30 Apr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
58 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05330156
Sponsor's protocol ID
TURP
Acronym
Prostate
Status last verified
Apr 2022
First submitted
28 Mar 2022
Last updated
15 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Mostafa MM, Ibrahim AF, Moeen AM, Elgammal MA, El-Azab AS, Faragallah MA. Bipolar resection versus enucleation of the prostate in management of benign prostatic hyperplasia patients with large-sized prostates: a prospective randomized controlled clinical trial. BMC Urol. 2026 Jan 24;26(1):52. doi: 10.1186/s12894-025-02004-1.

    PubMed 41580733

Questions about this trial

What is this clinical trial studying?

A study testing Transurethral resection of the prostate and transurethral enucleation of prostate in people with BPH, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ahmed F Hassan, Master (01069569946, ahmedfarahat358@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time of operation (time frame: intraoperative (from the start of resection or enucleation till the fixation of urethral catheter)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05330156, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in